top of page
Novartis celebrates Canada-wide implementation of newborn screening for spinal muscular atrophy
Novartis applauds Muscular Dystrophy Canada to ensure that every newborn in Canada will be screened to detect spinal muscular atrophy (SMA).
Aug 20, 20242 min read
Health Canada grants approval of the Eye-Tracking Neurological Assessment for Multiple Sclerosis (ETNAâ„¢-MS) for use in tracking disease progression in people living with MS
More than 90,000 Canadians live with multiple sclerosis (MS), a neurodegenerative, chronic condition that affects the central nervous system
Mar 25, 20244 min read
bottom of page